Genome-wide association study identifies genetic variants which predict the response of bone mineral density to teriparatide therapy
20 Mar 2023 in Annals of the Rheumatic Diseases
Research output: Contribution to Journal › Article (E-pub ahead of print)
Evaluation of supported self-management in gout (GoutSMART): a randomised controlled feasibility trial
May 2022 in The Lancet Rheumatology, vol. 4, pp. e320-e328
DOI: https://doi.org/10.1016/S2665-9913(22)00062-5
Research output: Contribution to Journal › Article (Published)
Long term effects of teriparatide followed by antiresorptive therapy on clinical outcomes in patients with severe spinal osteoporosis
21 May 2019 in Calcified Tissue International and Musculoskeletal Research
DOI: https://doi.org/10.1007/s00223-019-00563-8
Research output: Contribution to Journal › Article (E-pub ahead of print)
Point-of-care uric acid testing is useful in routine clinical care of gout
9 May 2019 in Arthritis Research and Therapy, vol. 21, pp. 117
DOI: https://doi.org/10.1186/s13075-019-1891-1
Research output: Contribution to Journal › Article (Published)
Identification of a novel locus on chromosome 2q13 which predisposes to clinical vertebral fractures independently of bone density
(8 pages) Mar 2018 in Annals of the Rheumatic Diseases, vol. 77, pp. 378-385
DOI: https://doi.org/10.1136/annrheumdis-2017-212469
Research output: Contribution to Journal › Article (Published)